HIV-1 Reverse Transcriptase Dimerization as a Drug Target

来源 :2006中国天津世界艾滋病日科技会议 | 被引量 : 0次 | 上传用户:yigeyige
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The HIV-1 reverse transcriptase (RT) has been a successful target for chemotherapeutic intervention.However,new drugs are urgently needed for systemic or for topical use as a microbicide due to the eventual emergence of drug-resistant strains of HIV-1 to currently available agents.The HIV-1 RT is an asymmetric dimer comprising a p66 and a p51 subunit,where the smaller subunit is the N-terminal cleavage product of p66.Studies by our group and others have demonstrated that the abrogation,destablisation or enlancement of RT dimerization impairs RT function.
其他文献
会议
会议
会议
会议
会议
会议
会议
会议
Viruses,by definition,are obligate intracellular pathogens and therefore,successful vaccination must induce cellmediated immunity for effective control and/or prevention of disease.Since HIV-1 is pred
会议
FusoGen Pharmaceuticals,Inc.is a leading Chinese biotech company based in Tianjin and Beijing,China.The company was founded in 2002 by Jason G.Zhou,an expert in structural biology and computer-assiste
会议